| UniProt ID | LACB2_HUMAN | |
|---|---|---|
| UniProt AC | Q53H82 | |
| Protein Name | Endoribonuclease LACTB2 {ECO:0000303|PubMed:26826708} | |
| Gene Name | LACTB2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 288 | |
| Subcellular Localization | Mitochondrion matrix . | |
| Protein Description | Endoribonuclease; cleaves preferentially 3' to purine-pyrimidine dinucleotide motifs in single-stranded RNA. The cleavage product contains a free 3' -OH group. Has no activity with double-stranded RNA or DNA. Required for normal mitochondrial function and cell viability.. | |
| Protein Sequence | MAAVLQRVERLSNRVVRVLGCNPGPMTLQGTNTYLVGTGPRRILIDTGEPAIPEYISCLKQALTEFNTAIQEIVVTHWHRDHSGGIGDICKSINNDTTYCIKKLPRNPQREEIIGNGEQQYVYLKDGDVIKTEGATLRVLYTPGHTDDHMALLLEEENAIFSGDCILGEGTTVFEDLYDYMNSLKELLKIKADIIYPGHGPVIHNAEAKIQQYISHRNIREQQILTLFRENFEKSFTVMELVKIIYKNTPENLHEMAKHNLLLHLKKLEKEGKIFSNTDPDKKWKAHL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 12 | Phosphorylation | LQRVERLSNRVVRVL HHHHHHHHHCEEEEC | 28.89 | 22210691 | |
| 91 | 2-Hydroxyisobutyrylation | GGIGDICKSINNDTT CCHHHHHHHCCCCCC | 55.49 | - | |
| 91 | Ubiquitination | GGIGDICKSINNDTT CCHHHHHHHCCCCCC | 55.49 | - | |
| 97 | Phosphorylation | CKSINNDTTYCIKKL HHHCCCCCCEEEEEC | 23.07 | 28152594 | |
| 98 | Phosphorylation | KSINNDTTYCIKKLP HHCCCCCCEEEEECC | 21.18 | 28152594 | |
| 99 | Phosphorylation | SINNDTTYCIKKLPR HCCCCCCEEEEECCC | 8.35 | 28152594 | |
| 102 | 2-Hydroxyisobutyrylation | NDTTYCIKKLPRNPQ CCCCEEEEECCCCCC | 44.70 | - | |
| 102 | Acetylation | NDTTYCIKKLPRNPQ CCCCEEEEECCCCCC | 44.70 | 23954790 | |
| 102 | Ubiquitination | NDTTYCIKKLPRNPQ CCCCEEEEECCCCCC | 44.70 | 19608861 | |
| 103 | Ubiquitination | DTTYCIKKLPRNPQR CCCEEEEECCCCCCC | 43.76 | - | |
| 121 | Phosphorylation | IGNGEQQYVYLKDGD CCCCCEEEEEECCCC | 7.25 | 27642862 | |
| 125 | Ubiquitination | EQQYVYLKDGDVIKT CEEEEEECCCCEEEE | 41.81 | 21906983 | |
| 131 | Ubiquitination | LKDGDVIKTEGATLR ECCCCEEEECCCEEE | 40.13 | 21906983 | |
| 141 | Phosphorylation | GATLRVLYTPGHTDD CCEEEEEECCCCCCC | 14.18 | 21406692 | |
| 142 | Phosphorylation | ATLRVLYTPGHTDDH CEEEEEECCCCCCCC | 20.73 | 21406692 | |
| 146 | Phosphorylation | VLYTPGHTDDHMALL EEECCCCCCCCHHHH | 49.38 | 21406692 | |
| 162 | Phosphorylation | EEENAIFSGDCILGE HHHCCEEECCCCCCC | 27.84 | 21406692 | |
| 171 | Phosphorylation | DCILGEGTTVFEDLY CCCCCCCCCHHHHHH | 18.58 | 21406692 | |
| 172 | Phosphorylation | CILGEGTTVFEDLYD CCCCCCCCHHHHHHH | 33.77 | 21406692 | |
| 178 | Phosphorylation | TTVFEDLYDYMNSLK CCHHHHHHHHHHHHH | 19.83 | 21406692 | |
| 180 | Phosphorylation | VFEDLYDYMNSLKEL HHHHHHHHHHHHHHH | 5.66 | 21406692 | |
| 183 | Phosphorylation | DLYDYMNSLKELLKI HHHHHHHHHHHHHHH | 25.04 | 21406692 | |
| 191 | Acetylation | LKELLKIKADIIYPG HHHHHHHCCCEECCC | 38.12 | 30589807 | |
| 191 | Ubiquitination | LKELLKIKADIIYPG HHHHHHHCCCEECCC | 38.12 | - | |
| 191 | 2-Hydroxyisobutyrylation | LKELLKIKADIIYPG HHHHHHHCCCEECCC | 38.12 | - | |
| 209 | Acetylation | VIHNAEAKIQQYISH CCCCHHHHHHHHHHC | 32.33 | 26051181 | |
| 213 | Phosphorylation | AEAKIQQYISHRNIR HHHHHHHHHHCCCCC | 6.50 | 28152594 | |
| 215 | Phosphorylation | AKIQQYISHRNIREQ HHHHHHHHCCCCCHH | 16.09 | 28152594 | |
| 235 | Phosphorylation | FRENFEKSFTVMELV HHHCHHHCCCHHHHH | 20.96 | - | |
| 247 | Ubiquitination | ELVKIIYKNTPENLH HHHHHHHHCCCCHHH | 43.89 | 19608861 | |
| 247 | Acetylation | ELVKIIYKNTPENLH HHHHHHHHCCCCHHH | 43.89 | 23236377 | |
| 247 | Malonylation | ELVKIIYKNTPENLH HHHHHHHHCCCCHHH | 43.89 | 26320211 | |
| 249 | Phosphorylation | VKIIYKNTPENLHEM HHHHHHCCCCHHHHH | 28.03 | - | |
| 258 | Acetylation | ENLHEMAKHNLLLHL CHHHHHHHHHHHHHH | 31.54 | 25825284 | |
| 266 | Ubiquitination | HNLLLHLKKLEKEGK HHHHHHHHHHHHCCC | 44.56 | - | |
| 266 | 2-Hydroxyisobutyrylation | HNLLLHLKKLEKEGK HHHHHHHHHHHHCCC | 44.56 | - | |
| 267 | Acetylation | NLLLHLKKLEKEGKI HHHHHHHHHHHCCCC | 69.14 | 20167786 | |
| 273 | Acetylation | KKLEKEGKIFSNTDP HHHHHCCCCCCCCCC | 41.49 | 130447 | |
| 273 | Succinylation | KKLEKEGKIFSNTDP HHHHHCCCCCCCCCC | 41.49 | - | |
| 273 | Succinylation | KKLEKEGKIFSNTDP HHHHHCCCCCCCCCC | 41.49 | - | |
| 282 | 2-Hydroxyisobutyrylation | FSNTDPDKKWKAHL- CCCCCCCCCCHHCC- | 66.96 | - | |
| 282 | Acetylation | FSNTDPDKKWKAHL- CCCCCCCCCCHHCC- | 66.96 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of LACB2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of LACB2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of LACB2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| NDRG3_HUMAN | NDRG3 | physical | 22939629 | |
| PALM2_HUMAN | PALM2 | physical | 22939629 | |
| P4R3B_HUMAN | SMEK2 | physical | 22939629 | |
| COIL_HUMAN | COIL | physical | 22939629 | |
| PO210_HUMAN | NUP210 | physical | 22939629 | |
| SPSY_HUMAN | SMS | physical | 22939629 | |
| SSU72_HUMAN | SSU72 | physical | 22939629 | |
| UBE2H_HUMAN | UBE2H | physical | 22939629 | |
| TXNL1_HUMAN | TXNL1 | physical | 22939629 | |
| NAGK_HUMAN | NAGK | physical | 21988832 | |
| OGA_HUMAN | MGEA5 | physical | 26186194 | |
| G6PI_HUMAN | GPI | physical | 26344197 | |
| PDC6I_HUMAN | PDCD6IP | physical | 26344197 | |
| OGA_HUMAN | MGEA5 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-247, AND MASS SPECTROMETRY. | |